Gene: GPR19
Official Full Name: G protein-coupled receptor 19provided by HGNC
Gene Summary: Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Located in cilium. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37533 | GPR19 Knockout cell line (HCT 116) | Human | GPR19 | 1:2~1:4 | Negative | Online Inquiry |
KO37534 | GPR19 Knockout cell line (A549) | Human | GPR19 | 1:3~1:4 | Negative | Online Inquiry |
GPR19 Gene Knockout Cell Lines are advanced biological research tools that have been specifically engineered to silence the GPR19 gene, which encodes a G-protein-coupled receptor involved in various physiological processes, including neuroprotection and inflammation. This knockout model allows researchers to investigate the gene's role more critically, facilitating a deeper understanding of its function in health and disease.
The key mechanism behind GPR19 Gene Knockout Cell Lines involves targeted gene editing strategies, such as CRISPR-Cas9 technology, which enables precise modifications to the genomic DNA. By disrupting the GPR19 gene, these cell lines provide an invaluable platform for studying receptor signaling pathways and downstream biological processes that may contribute to various pathological conditions, including neurodegenerative diseases and metabolic disorders. The ability to analyze cellular responses in the absence of this receptor allows researchers to elucidate its contributions to physiological and pathological states.
The scientific significance of GPR19 Gene Knockout Cell Lines extends to various applications in both research and clinical settings. They serve as pivotal models for drug discovery, toxicology studies, and functional genomics, enabling exploration of therapeutic targets while offering insights into potential side effects of pharmaceutical compounds. Additionally, the role of GPR19 in immune modulation presents opportunities for studying its implications in autoimmune and inflammatory diseases.
What sets our GPR19 Gene Knockout Cell Lines apart from alternative models is their high efficiency, robust performance, and reproducibility, ensuring that your experiments yield reliable and consistent results. Furthermore, our cell lines are thoroughly characterized, with detailed documentation and support, allowing researchers to confidently integrate them into their investigations.
For researchers, clinicians, and pharmaceutical developers, the GPR19 Gene Knockout Cell Lines represent a significant tool that enhances the ability to unravel complex biological networks. By leveraging these innovative models, users can accelerate their understanding of GPR19's role in disease mechanisms, ultimately leading to the development of novel therapeutics.
Our company prides itself on delivering premium, well-validated biological products, backed by a team of experts dedicated to advancing scientific research and innovation. With our GPR19 Gene Knockout Cell Lines, you gain access to a cutting-edge resource that empowers your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.